Life Real secures multimillion-yuan Series A+ round

On July 16, Life Real announced that it has received tens of millions of yuan in Series A+ strategic investment from Zheshang Venture Capital and Zhejiang University Future Medical Innovation Fund.

On July 16, Life Real announced that it has received tens of millions of yuan in Series A+ strategic investment from Zheshang Venture Capital and Zhejiang University Future Medical Innovation Fund.

Hangzhou-based Life Real is a high-tech biological company founded by Dr. Zhao Huai’s team at Zhejiang University. The company is a producer of life science and clinical diagnostic products.

The company’s products include autoclavable pipette, pipette controller, micro uv spectorphotometer, geneReady homogenizer, and AIGS, enabling scientists to conduct lab experiments and testing safely and conveniently.

Life Real has a 2,000 square meters production base in Hangzhou Future Sci-Tech City, and has established extensive business channels in foreign countries.

The company’s fully automatic integrated clinical diagnostic equipment has been developed.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/07/20/life-real-secures-multimillion-yuan-series-a-round/.

Leave a Reply

Please Login to Comment